Advertisement admin, Author at Pharmaceutical Business review - Page 405 of 458
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by >>> https://t.me/+vCnQzRypNr0xZWRi#zgbasw <<< 56321668 >>> https://t.me/+vCnQzRypNr0xZWRi#zgbasw <<< 56321668

Basilea begins BAL30072 pharmacokinetic Phase 1 study

The injectable sulfactam antibiotic has the potential to target clinically relevant gram-negative bacteria resistant to multiple drugs including Pseudomonas or Acinetobacter species. Basilea chief medical officer Prof. Achim